BRIEF-Argent Biopharma Ltd To Delist from London Stock Exchange

Reuters
29 Nov 2024
BRIEF-Argent Biopharma Ltd To Delist from London Stock Exchange

Nov 29 (Reuters) - London Stock Exchange Group PLC LSEG.L:

  • ARGENT BIOPHARMA LTD - ASX & LSE LISTING UPDATE

  • ARGENT BIOPHARMA LTD: NOTICE OF INTENTION TO DELIST FROM LONDON STOCK EXCHANGE

  • ARGENT BIOPHARMA LTD: WILL MAINTAIN ITS LISTINGS ON ASX AND OTCQB VENTURE MARKET

Source text: [ID:]

Further company coverage: LSEG.L

(Reporting by Tom Wilson)

((T.Wilson@thomsonreuters.com; Reuters Messaging: t.wilson.thomsonreuters.com@reuters.net))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10